Aeon Formulations Profile
Key Indicators
- Authorised Capital ₹ 6.00 Cr
as on 24-10-2024
- Paid Up Capital ₹ 5.95 Cr
as on 24-10-2024
- Company Age 16 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 6.00 Cr
as on 24-10-2024
- Satisfied Charges ₹ 10.12 Cr
as on 24-10-2024
- Revenue 6.78%
(FY 2023)
- Profit -6.72%
(FY 2023)
- Ebitda -4.53%
(FY 2023)
- Net Worth 29.21%
(FY 2023)
- Total Assets 43.14%
(FY 2023)
About Aeon Formulations
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 6.00 Cr and a paid-up capital of Rs 5.95 Cr.
The company currently has active open charges totaling ₹6.00 Cr. The company has closed loans amounting to ₹10.12 Cr, as per Ministry of Corporate Affairs (MCA) records.
Vijayarani Vaitheeswaran and Ariarasudhan Vaitheeswaran serve as directors at the Company.
- CIN/LLPIN
U33110TN2008PTC069867
- Company No.
069867
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Nov 2008
- Date of AGM
26 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Kanchipuram, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Aeon Formulations Private Limited offer?
Aeon Formulations Private Limited offers a wide range of products and services, including Digestive System Drugs & Medicines, Gastrointestinal Drugs, Common Disease Medicines, Antihistamines, Healthcare Products & Aids, Health Drinks, Anti Infective Drugs & Medicines, Antibacterial Drugs, Antibiotic Tablets, Capsule & Syrup, Cardiac Drugs.
Who are the key members and board of directors at Aeon Formulations?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vijayarani Vaitheeswaran  | Director | 17-Feb-2014 | Current |
| Ariarasudhan Vaitheeswaran | Director | 05-Mar-2020 | Current |
Financial Performance of Aeon Formulations.
Aeon Formulations Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 6.78% increase. The company also saw a slight decrease in profitability, with a 6.72% decrease in profit. The company's net worth Soared by an impressive increase of 29.21%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aeon Formulations?
In 2023, Aeon Formulations had a promoter holding of 80.46% and a public holding of 19.54%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Eesun Enterprises India Private LimitedActive 16 years 1 monthVijayarani Vaitheeswaran is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 07 May 2024 | ₹6.00 Cr | Open |
Canara Bank Creation Date: 06 Jan 2012 | ₹10.07 Cr | Satisfied |
Indian Bank Creation Date: 31 Oct 2009 | ₹0.50 M | Satisfied |
How Many Employees Work at Aeon Formulations?
Aeon Formulations has a workforce of 92 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aeon Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aeon Formulations's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
